Germline variants in IL4, MGMT and AKT1 are associated with prostate cancer-specific mortality: An analysis of 12,082 prostate cancer cases
LM FitzGerald, S Zhao, A Leonardson, MS Geybels, S Kolb, DW Lin, JL Wright, R Eeles, Z Kote-Jarai, K Govindasami, GG Giles, MC Southey, J Schleutker, TL Tammela, C Sipeky, KL Penney, MJ Stampfer, H Gronberg, F Wiklund, P Stattin Show all
Prostate Cancer and Prostatic Diseases | NATURE PUBLISHING GROUP | Published : 2018
Awarded by National Cancer Institute
Awarded by NATIONAL CANCER INSTITUTE
Awarded by NATIONAL HEART, LUNG, AND BLOOD INSTITUTE
Awarded by NATIONAL HUMAN GENOME RESEARCH INSTITUTE
This work was supported by awards from the Movember Foundation (to R.E. and J.L.S.) and grants from the National Cancer Institute (P50 CA097186 and K05 CA175147 to J.L.S.), with additional support from the Fred Hutchinson Cancer Research Center.